Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Raises Guidance as It Looks to the Pipeline for Growth


Biogen (NASDAQ: BIIB) put up relatively impressive sales numbers in the second quarter, with earnings per share growing like gangbusters as the drugmaker cut expenses and repurchased shares to boost the bottom line.

Metric

Q2 2019

Continue reading


Quelle Fool.com

Like: 0
Share

Comments